Detalhe da pesquisa
1.
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 26(10): e1742-e1750, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34156726
2.
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 26(5): 397-405, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33634507
3.
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
Oncologist
; 26(12): 1017-1025, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34342095
4.
Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma.
Br J Cancer
; 123(8): 1228-1234, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32704173
5.
Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist
; 25(3): e484-e491, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162798
6.
Time-dependent effects of prognostic biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma.
Tumour Biol
; 39(6): 1010428317705514, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28618965
7.
External validation of the modified Glasgow prognostic score for renal cancer.
Indian J Urol
; 30(1): 33-7, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24497679
8.
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810.
J Clin Oncol
; : JCO2301544, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531002
9.
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients.
Clin Genitourin Cancer
; 20(1): 53-59, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34922840
10.
Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.
J Immunother Precis Oncol
; 5(3): 52-57, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36034580
11.
Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients.
Tumour Biol
; 32(2): 375-80, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21086092
12.
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
J Immunother Cancer
; 9(7)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34326170
13.
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade.
Front Oncol
; 11: 701345, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34222024
14.
Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib.
Cancer Treat Res Commun
; 28: 100393, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34029879
15.
Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.
Front Oncol
; 11: 707050, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34307176
16.
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.
Cancer Med
; 9(8): 2752-2760, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32100417
17.
A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors.
Clin Cancer Res
; 26(11): 2497-2505, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32005746
18.
Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab.
Clin Genitourin Cancer
; 16(3): e563-e575, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29402706
19.
Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
Anticancer Res
; 27(3B): 1483-8, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17595765
20.
A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma.
Asian J Urol
; 4(4): 230-238, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29387555